Koninklijke Philips N.V. (NL:PHIA)
:PHIA
Want to see NL:PHIA full AI Analyst Report?
Top Page
Koninklijke Philips N.V.
(PHIA)
Select Model
Select Model
Rating:64Neutral
Price Target:
€24.50
▼(-0.73% Downside)
Action:ReiteratedDate:02/18/26
The score is driven primarily by improving financial performance (profitability rebound and strong 2025 free cash flow), supported by a clear uptrend in technicals. These positives are tempered by historical earnings volatility and a mixed valuation profile (higher P/E despite a solid dividend yield).
Positive Factors
Diversified recurring revenue mix
Philips’ business model combines large-capital equipment sales with recurring service contracts, software/informatics and consumables. This installed-base-driven revenue mix supports durable recurring cash flows, higher lifecycle margins and long-term customer stickiness versus single-sale models.
Negative Factors
Historic earnings volatility
Material profit and cash-flow swings across 2022–2025 reduce predictability of margins and make capital allocation and forecasting harder. Persistent volatility undermines confidence in consistent long-term earnings and could constrain strategic planning.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified recurring revenue mix
Philips’ business model combines large-capital equipment sales with recurring service contracts, software/informatics and consumables. This installed-base-driven revenue mix supports durable recurring cash flows, higher lifecycle margins and long-term customer stickiness versus single-sale models.
Read all positive factors
Koninklijke Philips N.V. (PHIA) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€23.49B
Dividend Yield3.73%
Average Volume (3M)1.33M
Price to Earnings (P/E)24.6
Beta (1Y)0.96
Revenue Growth-0.81%
EPS Growth-54.90%
CountryNL
Employees67,247
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.60
Shares Outstanding962,920,100
10 Day Avg. Volume1,198,930
30 Day Avg. Volume1,333,770
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.01
Price to Sales (P/S)1.24
P/FCF Ratio24.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€27.00Price Target Upside9.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)1.53
Revenue Forecast (FY)€17.87B
Koninklijke Philips N.V. Business Overview & Revenue Model
Company Description
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides d...
How the Company Makes Money
Philips primarily makes money by selling health-technology equipment, associated consumables, software, and services to healthcare providers and, in certain categories, to consumers. Key revenue streams typically include: (1) hardware and system s...
Koninklijke Philips N.V. Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
62
Positive
Cash Flow
66
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.83B | 18.02B | 18.17B | 17.83B | 17.16B |
| Gross Profit | 8.06B | 7.77B | 7.45B | 7.19B | 7.17B |
| EBITDA | 2.77B | 1.85B | 1.04B | -280.00M | 1.73B |
| Net Income | 896.00M | -702.00M | -466.00M | -1.61B | 3.32B |
Balance Sheet | |||||
| Total Assets | 26.94B | 28.98B | 29.41B | 30.69B | 30.96B |
| Cash, Cash Equivalents and Short-Term Investments | 2.79B | 2.40B | 1.87B | 1.18B | 2.31B |
| Total Debt | 8.09B | 7.49B | 7.69B | 8.20B | 6.98B |
| Total Liabilities | 15.96B | 16.93B | 17.34B | 17.41B | 16.49B |
| Stockholders Equity | 10.96B | 12.01B | 12.03B | 13.25B | 14.44B |
Cash Flow | |||||
| Free Cash Flow | 903.00M | 893.00M | 1.49B | -979.00M | 866.00M |
| Operating Cash Flow | 1.17B | 1.57B | 2.14B | -173.00M | 1.63B |
| Investing Cash Flow | -747.00M | -573.00M | -636.00M | -1.49B | -3.67B |
| Financing Cash Flow | 107.00M | -496.00M | -848.00M | 500.00M | -2.35B |
Koninklijke Philips N.V. Technical Analysis
Positive
24.68
Price Trends
24.96
Positive
24.48
Positive
23.93
Positive
Market Momentum
0.04
Negative
62.74
Neutral
91.42
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:PHIA, the sentiment is Positive. The current price of 24.68 is above the 20-day moving average (MA) of 23.80, below the 50-day MA of 24.96, and above the 200-day MA of 23.93, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 62.74 is Neutral, neither overbought nor oversold. The STOCH value of 91.42 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:PHIA.
Koninklijke Philips N.V. Peers Comparison
UnderperformOutperform
Sector (55)
NL:PHIA
Koninklijke Philips N.V.
25.35
5.01
24.65%
NL:PHARM
Pharming Group
1.49
0.79
112.98%
NL:GLPG
Galapagos
24.70
2.86
13.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.